scholarly journals Alterations in B cell development, CDR-H3 repertoire and dsDNA-binding antibody production among C57BL/6 ΔD−iD mice congenic for the lupus susceptibility loci sle1, sle2 or sle3

Autoimmunity ◽  
2017 ◽  
Vol 50 (1) ◽  
pp. 42-51
Author(s):  
Mohamed Khass ◽  
Robert L. Schelonka ◽  
Cun Ren Liu ◽  
Ada Elgavish ◽  
Laurence Morel ◽  
...  
2010 ◽  
Vol 30 (4) ◽  
pp. 327-344 ◽  
Author(s):  
Harry W. Schroeder, Jr. ◽  
Michael Zemlin ◽  
Mohamed Khass ◽  
Huan H. Nguyen ◽  
Robert L. Schelonka

2010 ◽  
Vol 31 (2) ◽  
pp. 253-264 ◽  
Author(s):  
Bongkum Choi ◽  
Eunyoung Chun ◽  
Miyoung Kim ◽  
Seong-Tae Kim ◽  
Keejung Yoon ◽  
...  

2006 ◽  
Vol 203 (6) ◽  
pp. 1567-1578 ◽  
Author(s):  
Gregory C. Ippolito ◽  
Robert L. Schelonka ◽  
Michael Zemlin ◽  
Ivaylo I. Ivanov ◽  
Ryoki Kobayashi ◽  
...  

Tyrosine and glycine constitute 40% of complementarity determining region 3 of the immunoglobulin heavy chain (CDR-H3), the center of the classic antigen-binding site. To assess the role of DH RF1-encoded tyrosine and glycine in regulating CDR-H3 content and potentially influencing B cell function, we created mice limited to a single DH encoding asparagine, histidine, and arginines in RF1. Tyrosine and glycine content in CDR-H3 was halved. Bone marrow and spleen mature B cell and peritoneal cavity B-1 cell numbers were also halved, whereas marginal zone B cell numbers increased. Serum immunoglobulin G subclass levels and antibody titers to T-dependent and T-independent antigens all declined. Thus, violation of the conserved preference for tyrosine and glycine in DH RF1 alters CDR-H3 content and impairs B cell development and antibody production.


2008 ◽  
Vol 181 (12) ◽  
pp. 8409-8415 ◽  
Author(s):  
Robert L. Schelonka ◽  
Michael Zemlin ◽  
Ryoki Kobayashi ◽  
Gregory C. Ippolito ◽  
Yingxin Zhuang ◽  
...  

Immunology ◽  
2020 ◽  
Vol 162 (1) ◽  
pp. 58-67
Author(s):  
Verónica Calonga‐Solís ◽  
Leonardo M. Amorim ◽  
Ticiana D. J. Farias ◽  
Maria Luiza Petzl‐Erler ◽  
Danielle Malheiros ◽  
...  

Blood ◽  
2008 ◽  
Vol 112 (5) ◽  
pp. 1570-1580 ◽  
Author(s):  
Tucker W. LeBien ◽  
Thomas F. Tedder

Abstract The discovery that lymphocyte subpopulations participate in distinct components of the immune response focused attention onto the origins and function of lymphocytes more than 40 years ago. Studies in the 1960s and 1970s demonstrated that B and T lymphocytes were responsible primarily for the basic functions of antibody production and cell-mediated immune responses, respectively. The decades that followed have witnessed a continuum of unfolding complexities in B-cell development, subsets, and function that could not have been predicted. Some of the landmark discoveries that led to our current understanding of B lymphocytes as the source of protective innate and adaptive antibodies are highlighted in this essay. The phenotypic and functional diversity of B lymphocytes, their regulatory roles independent of antibody production, and the molecular events that make this lineage unique are also considered. Finally, perturbations in B-cell development that give rise to certain types of congenital immunodeficiency, leukemia/lymphoma, and autoimmune disease are discussed in the context of normal B-cell development and selection. Despite the significant advances that have been made at the cellular and molecular levels, there is much more to learn, and cross-disciplinary studies in hematology and immunology will continue to pave the way for new discoveries.


2019 ◽  
Vol 26 (12) ◽  
pp. 940-948
Author(s):  
Yang Zheng ◽  
Man M. Zong ◽  
Bo Y. Chen ◽  
Xiao H. Zhou ◽  
Zi N. Liu ◽  
...  

Background: Bursa of Fabricius plays the vital functions on B cell development and antibody production in poultry. The bursal-derived peptide plays the essential roles on avian immature B cell development. Objectives: Here we explored the functions of the recently reported bursal nonapeptide (BP9) on the antibody production and the molecular basis of BP9 on avian immature B cell. Methods: Chicken were twice immunized with Avian Influenza Virus (AIV) inactivated vaccine plus with BP9 at three dosages, respectively. On two weeks after the second immunization, sera samples were collected from all experimental groups to measure AIV-specific Agglutination Inhibition (HI) antibody titers. Also, on 7th day after the second immunization, spleen lymphocytes were isolated from the immunized chicken to detect the lymphocyte viabilities. DT40 cells were treated with BP9 from 0.02 to 2 μg/mL for 4 and 20h to detect sIgM mRNA levels, and total RNAs from BP9-treated DT40 cells were collected to investigate the gene expression profiles of DT40 cells, and to analyze the enriched pathways and functional biological processes. Finally, nine gene expressions were validated with quantitative PCR (qPCR). Results: Our investigation proved the strong regulatory roles of BP9 on AIV-specific HI antibody titers and lymphocyte viabilities. BP9 promoted sIgM mRNA levels in DT40 cells, and upregulated 598 gene expressions and downregulated 395 gene expressions in DT40 cells with 0.2μg/mL BP9 treatment. Moreover, our findings verified the significantly enriched six pathways and various the biological functional processes of BP9 on avian immature B cell. Also, we found eight signaling pathways in the enriched biological processes of BP9-treated DT40 cells, and the expressions of nine selected genes with qPCR were identical to that of microarray data. Conclusion: BP9 promoted the antibody production in the 21-old-day chicken immunization, and stimulated the sIgM expression in DT40 cells. Furthermore, we analyzed the gene expression profile and immune-related biological processes of DT40 cells treated with BP9, which provided some new insights into the mechanism on immature B cell development, and provided important references for adjuvant development on vaccine improvement and clinical application.


Sign in / Sign up

Export Citation Format

Share Document